The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Blue Eye Disease Vaccines-Global Market Insights and Sales Trends 2024

Blue Eye Disease Vaccines-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1838343

No of Pages : 94

Ask Your Query
Synopsis
PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
The global Blue Eye Disease Vaccines market size is expected to reach US$ 212.8 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Blue Eye Disease Vaccines in various end use industries. The expanding demands from the Piglets and Adult Pigs, are propelling Blue Eye Disease Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blue Eye Disease Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blue Eye Disease Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blue Eye Disease Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blue Eye Disease Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blue Eye Disease Vaccines covered in this report include CAHIC, Boehringer Ingelheim, MSD Animal Health, Chopper Biology, Ceva, Ringpu Biology, Qilu Animal and DHN, etc.
The global Blue Eye Disease Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
Global Blue Eye Disease Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blue Eye Disease Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Blue Eye Disease Vaccines market, by Application
Piglets
Adult Pigs
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blue Eye Disease Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Blue Eye Disease Vaccines Market Overview
1.1 Blue Eye Disease Vaccines Product Overview
1.2 Blue Eye Disease Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Blue Eye Disease Vaccines Market Size by Type
1.3.1 Global Blue Eye Disease Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Blue Eye Disease Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Blue Eye Disease Vaccines Sales Breakdown by Type (2018-2023)
2 Global Blue Eye Disease Vaccines Market Competition by Company
2.1 Global Top Players by Blue Eye Disease Vaccines Sales (2018-2023)
2.2 Global Top Players by Blue Eye Disease Vaccines Revenue (2018-2023)
2.3 Global Top Players by Blue Eye Disease Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Blue Eye Disease Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Blue Eye Disease Vaccines Market Competitive Situation and Trends
2.5.1 Blue Eye Disease Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Blue Eye Disease Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Blue Eye Disease Vaccines Market
2.8 Key Manufacturers Blue Eye Disease Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Blue Eye Disease Vaccines Status and Outlook by Region
3.1 Global Blue Eye Disease Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Blue Eye Disease Vaccines Historic Market Size by Region
3.2.1 Global Blue Eye Disease Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Blue Eye Disease Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Blue Eye Disease Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Region
3.3.1 Global Blue Eye Disease Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Blue Eye Disease Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Blue Eye Disease Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Blue Eye Disease Vaccines by Application
4.1 Blue Eye Disease Vaccines Market Segment by Application
4.1.1 Piglets
4.1.2 Adult Pigs
4.2 Global Blue Eye Disease Vaccines Market Size by Application
4.2.1 Global Blue Eye Disease Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Blue Eye Disease Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Blue Eye Disease Vaccines Sales Breakdown by Application (2018-2023)
5 North America Blue Eye Disease Vaccines by Country
5.1 North America Blue Eye Disease Vaccines Historic Market Size by Country
5.1.1 North America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Blue Eye Disease Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Blue Eye Disease Vaccines Sales in Value by Country (2018-2023)
5.2 North America Blue Eye Disease Vaccines Forecasted Market Size by Country
5.2.1 North America Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
6 Europe Blue Eye Disease Vaccines by Country
6.1 Europe Blue Eye Disease Vaccines Historic Market Size by Country
6.1.1 Europe Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Blue Eye Disease Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Blue Eye Disease Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Blue Eye Disease Vaccines Forecasted Market Size by Country
6.2.1 Europe Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Blue Eye Disease Vaccines by Region
7.1 Asia-Pacific Blue Eye Disease Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Blue Eye Disease Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Blue Eye Disease Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Blue Eye Disease Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Blue Eye Disease Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Blue Eye Disease Vaccines Sales in Value by Region (2024-2029)
8 Latin America Blue Eye Disease Vaccines by Country
8.1 Latin America Blue Eye Disease Vaccines Historic Market Size by Country
8.1.1 Latin America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Blue Eye Disease Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Blue Eye Disease Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Blue Eye Disease Vaccines Forecasted Market Size by Country
8.2.1 Latin America Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Blue Eye Disease Vaccines by Country
9.1 Middle East and Africa Blue Eye Disease Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Blue Eye Disease Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Blue Eye Disease Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Blue Eye Disease Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Blue Eye Disease Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Blue Eye Disease Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CAHIC
10.1.1 CAHIC Company Information
10.1.2 CAHIC Introduction and Business Overview
10.1.3 CAHIC Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CAHIC Blue Eye Disease Vaccines Products Offered
10.1.5 CAHIC Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Blue Eye Disease Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 MSD Animal Health
10.3.1 MSD Animal Health Company Information
10.3.2 MSD Animal Health Introduction and Business Overview
10.3.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 MSD Animal Health Blue Eye Disease Vaccines Products Offered
10.3.5 MSD Animal Health Recent Development
10.4 Chopper Biology
10.4.1 Chopper Biology Company Information
10.4.2 Chopper Biology Introduction and Business Overview
10.4.3 Chopper Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chopper Biology Blue Eye Disease Vaccines Products Offered
10.4.5 Chopper Biology Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ceva Blue Eye Disease Vaccines Products Offered
10.5.5 Ceva Recent Development
10.6 Ringpu Biology
10.6.1 Ringpu Biology Company Information
10.6.2 Ringpu Biology Introduction and Business Overview
10.6.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ringpu Biology Blue Eye Disease Vaccines Products Offered
10.6.5 Ringpu Biology Recent Development
10.7 Qilu Animal
10.7.1 Qilu Animal Company Information
10.7.2 Qilu Animal Introduction and Business Overview
10.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Qilu Animal Blue Eye Disease Vaccines Products Offered
10.7.5 Qilu Animal Recent Development
10.8 DHN
10.8.1 DHN Company Information
10.8.2 DHN Introduction and Business Overview
10.8.3 DHN Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 DHN Blue Eye Disease Vaccines Products Offered
10.8.5 DHN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Blue Eye Disease Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Blue Eye Disease Vaccines Industrial Chain Analysis
11.4 Blue Eye Disease Vaccines Market Dynamics
11.4.1 Blue Eye Disease Vaccines Industry Trends
11.4.2 Blue Eye Disease Vaccines Market Drivers
11.4.3 Blue Eye Disease Vaccines Market Challenges
11.4.4 Blue Eye Disease Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Blue Eye Disease Vaccines Distributors
12.3 Blue Eye Disease Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock